Skip to main content
SpringerLink
Log in

Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma

  • Published:
Journal of Gastrointestinal Surgery

Abstract

It is not clear whether chronic hepatitis B or C virus (HBV or HCV) infection is a prognostic factor for hepatocellular carcinoma. We performed this study to determine if chronic HBV or HCV infection had any impact on postresection survival or affected patterns of failure. The records of 77 patients undergoing surgical resection for hepatocellular carcinoma between January 1990 and December 1998 were reviewed. Forty-four patients (57%) had HCV infection, 18 patients (23%) had HBV infection, and 15 patients (20%) had negative serology. There were no differences in age, sex, or tumor size among the groups, and all patients had margin-negative resections. There was a significantly higher incidence of satellitosis and vascular invasion in patients with HCV infection (32 % and 41 %, respectively; P <0.05 vs. other groups). With a median follow-up of 30 months, a significantly decreased local disease-free survival (LDFS) was seen in HBV-positive (5-year LDFS 26%) or HCV-positive (S-year LDFS 38%) patients compared to those with negative serology (S-year LDFS 79%; P <0.05). There was also a trend toward a decreased overall survival in patients with positive hepatitis serology compared to patients with negative serology (37% vs. 79%; P = 0.12). Uuivariate analysis revealed that only satellitosis was related to local recurrence and overall survival. Patients with positive serology for hepatitis B or C undergoing resection for hepatocellular carcinoma have a trend toward worse overall prognosis and a significantly decreased LDFS when compared to patients with negative serology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann Intern Med 1988;108:390–401.

    PubMed  Google Scholar 

  2. Beaseley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129–1133.

    Article  Google Scholar 

  3. Liaw YE, Lin DY, Chen TJ, Chu CM. Natural course after the development of cirrhosis in patients with chronic tyPe B hepatitis: A prospective study. Liver 1989;9:234–241.

    Google Scholar 

  4. Chen DS. From hepatitis to hepatoma: Lesions from type B viral hepatitis. Science 1993;262:369–370.

    Article  PubMed  CAS  Google Scholar 

  5. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992;15:948–963.

    Article  PubMed  CAS  Google Scholar 

  6. Villa E, Baldini GM, Pasquinelli C, Melegari M, Cariani E, Di Chirico G, Manenti E. Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. Cancer 1988;62:611–615.

    Article  PubMed  CAS  Google Scholar 

  7. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Katayama K, Fusamoto H, Kamada T. Hepatitis B virus marker and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992;37:65–72.

    Article  PubMed  CAS  Google Scholar 

  8. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K, Nakano M. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993;72:683–688.

    Article  PubMed  CAS  Google Scholar 

  9. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Flumgart L, Bremran M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28–34.

    Article  PubMed  CAS  Google Scholar 

  10. Yu SZ, Zi XL, Chen G. The relationship between viral hepatitis and primary liver cancer in four areas of China. Chung Hua Hsing Hsueh Tsa Chih 1997;18:214–216.

    CAS  Google Scholar 

  11. Olubuyide IO, Aliyu B, Olaelye OA, Ola SO, Olawuyi F, Mal-abu UH, Odemuyiwa SO, Odaibo GN, Cook GC. Hepatitis B and C virus and hepatocellular carcinoma. Trans R Sot Trop Med Hyg 1997;91:38–41.

    Article  CAS  Google Scholar 

  12. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 1998;27:574–578.

    Article  PubMed  CAS  Google Scholar 

  13. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, Tang JH, Wang JH, Chen CL, Chen WJ. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999;86:1143–1150.

    Article  PubMed  CAS  Google Scholar 

  14. Tabor E, Kobayashi K. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: Prevalence and structure—summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma. J Natl Cancer Inst 1992;84:86–90.

    Article  PubMed  CAS  Google Scholar 

  15. Yamanaka N, Okamoto E, Tbyosaka A, Mitnnobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E. Prognostic factors after hepatectomy for hepatocellular carcinomas. A uunivariate and multivariate analysis. Cancer 1990; 65:1104–1110.

    Article  PubMed  CAS  Google Scholar 

  16. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Arm Surg 1990;211:277.

    Google Scholar 

  17. Ozawa K, Takayasu T, Kumada K, Yamaoka Y, Tanaka K, Kobayashi N, Inamoto T, Shimahar Y, Mori K, Honda K. Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period. Am J Surg 1991;161:677–682.

    Article  PubMed  CAS  Google Scholar 

  18. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660–664.

    Article  PubMed  CAS  Google Scholar 

  19. Blumgart LH. Surgery of the Liver and Biliary Tract, vol 1. Edinburgh: Churchill Livingstone, 1988, pp 3–9.

    Google Scholar 

  20. Curley SA. Hepatocellular cancer. Curr Hepatol 1996;16:229–259.

    Google Scholar 

  21. Shiratori Y, Shiina S, Imamura M, Kato N. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027–1033.

    Article  PubMed  CAS  Google Scholar 

  22. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35:828–832.

    PubMed  CAS  Google Scholar 

  23. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307–310.

    Article  PubMed  CAS  Google Scholar 

  24. Haratake J, Takeda S, Kasai T, Nakano S, Tokui N. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer 1993;72:1178–1183.

    Article  PubMed  CAS  Google Scholar 

  25. Chen ME, Jeng LB, Lee WC, Chen TC. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepato-cellular carcinoma. Surgery 1998;123:554–559.

    Article  PubMed  CAS  Google Scholar 

  26. Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Kuroda N, Takada M, Okamoto E. Correlation of hepatitis vii-m serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997;79:1509–1515.

    Article  PubMed  CAS  Google Scholar 

  27. Shiraishi M, Hiroyasu S, Nagahama M, Tomita S, Miyahira T, Kusano T, Furukawa M, Muto Y. Characteristics of hepatocellular carcinoma in patients with negative virus markers: Clinicopathologic study of resected tumors. World J Surg 1999;23:301–305.

    Article  PubMed  CAS  Google Scholar 

  28. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabeis B, Nishizaki T, Yanaga K, Sugimachi K. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20–24.

    PubMed  CAS  Google Scholar 

  29. Wu CC, Ho WL, Chen JT, Tsang JS, Tang JS, Yeh DC, P’eng FK. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma. Br J Surg 1999;86:139l-1396.

    Article  Google Scholar 

  30. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y. Hepatic resection for hepatocellular carcinoma: Clinical features and long-term prognosis. Ann Surg 1987; 205:33–40.

    Article  PubMed  CAS  Google Scholar 

  31. Huang YH, Wu JC, Chau GY, Tsay SH, King KL, Sheng WY, Lui WY, Lee SD. Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol 1998;33:512–516.

    Article  PubMed  Google Scholar 

  32. Ko S, Nakajima Y, Kanehiro H, Kin T, Aomatsu Y, Yoshimura A, Taki J, Yagura K, Ohashi K, Nakano H. Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 1996;20:1082–1086.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 106, 77030, Houston, TX

    Syed A. Ahmad M.D., Malcolm M. Bilimoria M.D., Xuemei Wang, Francesco Izzo M.D., Paolo Delrio M.D., Paolo Marra M.D., Treneth P. Baker M.D., Geoff A. Porter M.D., Lee M. Ellis M.D., Jean N. Vauthey M.D., Sundar Dhamotharan M.D. & Steven A. Curley M.D.

Authors
  1. Syed A. Ahmad M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malcolm M. Bilimoria M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuemei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Izzo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Delrio M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paolo Marra M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Treneth P. Baker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Geoff A. Porter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lee M. Ellis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jean N. Vauthey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sundar Dhamotharan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Steven A. Curley M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Curley M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmad, S.A., Bilimoria, M.M., Wang, X. et al. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. J Gastrointest Surg 5, 468–476 (2001). https://doi.org/10.1016/S1091-255X(01)80084-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(01)80084-6

Key words

Search

Navigation